Bladder cancer is among the most prevalent urological cancers, with the majority being transitional cell carcinomas. Timely diagnosis and appropriate treatment are key to achieving the best outcomes. We offer a full spectrum of care from detection to long-term surveillance.

---

Types of Bladder Cancer

• Transitional Cell Carcinoma (Urothelial Carcinoma) – most common
• Squamous Cell Carcinoma
• Adenocarcinoma
• Non-muscle-invasive vs. Muscle-invasive Bladder Cancer

---

Signs & Symptoms

• Painless blood in urine (most common early sign)
• Frequent or urgent urination
• Pain during urination
• Pelvic or back pain
• Unexplained weight loss

---

Diagnosis

Accurate staging guides the treatment plan:

• Urine cytology and urine culture
• Cystoscopy – direct visualisation of the bladder
• TURBT (Transurethral Resection of Bladder Tumour) for biopsy and staging
• CT urogram and MRI for staging

---

Treatment Options

Treatment depends on the stage and grade of the tumour:

• TURBT – for non-muscle-invasive tumours
• Intravesical BCG or Chemotherapy – to prevent recurrence
• Radical Cystectomy – removal of the bladder for muscle-invasive disease
• Urinary Diversion or Neobladder – reconstruction after cystectomy
• Systemic Chemotherapy & Immunotherapy – for advanced disease

---

Surveillance & Follow-Up

Bladder cancer has a high recurrence rate. We provide structured follow-up with regular cystoscopy and imaging to detect any recurrence early and manage it promptly.